6-Acetyl-8-cyclopentyl-2-{[1-(methanesulfonyl)piperidin-4-yl]-amino}-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one

ID: ALA5280928

Chembl Id: CHEMBL5280928

Max Phase: Preclinical

Molecular Formula: C21H29N5O4S

Molecular Weight: 447.56

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)c1c(C)c2cnc(NC3CCN(S(C)(=O)=O)CC3)nc2n(C2CCCC2)c1=O

Standard InChI:  InChI=1S/C21H29N5O4S/c1-13-17-12-22-21(23-15-8-10-25(11-9-15)31(3,29)30)24-19(17)26(16-6-4-5-7-16)20(28)18(13)14(2)27/h12,15-16H,4-11H2,1-3H3,(H,22,23,24)

Standard InChI Key:  BMHDAQPPVLYLRR-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5280928

    ---

Associated Targets(Human)

CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E1 (1877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK4 Tclin Cyclin-dependent kinase 4/cyclin D1 (2340 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCND1 Tchem CDK6/cyclin D1 (322 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNT1 Tchem CDK9/cyclin T1 (2643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 447.56Molecular Weight (Monoisotopic): 447.1940AlogP: 2.25#Rotatable Bonds: 5
Polar Surface Area: 114.26Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.58CX LogP: 0.60CX LogD: 0.60
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.70Np Likeness Score: -1.28

References

1. Freeman-Cook KD, Hoffman RL, Behenna DC, Boras B, Carelli J, Diehl W, Ferre RA, He YA, Hui A, Huang B, Huser N, Jones R, Kephart SE, Lapek J, McTigue M, Miller N, Murray BW, Nagata A, Nguyen L, Niessen S, Ninkovic S, O'Doherty I, Ornelas MA, Solowiej J, Sutton SC, Tran K, Tseng E, Visswanathan R, Xu M, Zehnder L, Zhang Q, Zhang C, Dann S..  (2021)  Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer.,  64  (13.0): [PMID:34110834] [10.1021/acs.jmedchem.1c00159]

Source